PGV001
Showing 1 - 4 of 4
Urothelial/Bladder Cancer, Nos Trial in New York (Atezolizumab, PGV001, Poly ICLC)
Completed
- Urothelial/Bladder Cancer, Nos
- Atezolizumab
- +3 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Mar 7, 2022
Prostate Cancer Trial in New York (PGV-001, Poly-ICLC, CDX-301)
Recruiting
- Prostate Cancer
- PGV-001
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai (ISMMS)
Aug 10, 2021
Solid Tumors Trial in New York (Peptides, Poly-ICLC, Lenalidomide)
Completed
- Solid Tumors
- Peptides
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jan 7, 2021
Universal Germline Testing in the Community
Recruiting
- Cancer
- +2 more
- Invitae's 84 gene multi-cancer panel.
-
Rock Hill, South CarolinaCarolina Blood and Cancer Care Associates, PA'
Dec 5, 2022